Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Solid Tumor × Sirolimus × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Leukemia, Myeloid, Acute 20 Myelodysplastic Syndromes 18 Lymphoma, Non-Hodgkin 17 Leukemia, Lymphocytic, Chronic, B-Cell 15 Hodgkin Disease 15 Graft vs Host Disease 13 Lymphoma, Mantle-Cell 12 Leukemia 12 Multiple Myeloma 11 Lymphoma, Large B-Cell, Diffuse 11 Sarcoma 10 Lymphoma 10 Lymphoma, Follicular 9 Lymphoma, B-Cell, Marginal Zone 9 Burkitt Lymphoma 9 Myeloproliferative Disorders 8 Waldenstrom Macroglobulinemia 7 Tuberous Sclerosis 7 Neoplasms 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Hematologic Neoplasms 7 Congenital Abnormalities 7 Primary Myelofibrosis 6 Lymphoma, Large-Cell, Immunoblastic 6 Leukemia, Myelomonocytic, Chronic 6 Leukemia, Myeloid, Chronic-Phase 6 Leukemia, Myeloid, Accelerated Phase 6 Breast Neoplasms 6 Osteosarcoma 5

Interventions

apatinib 3 vistusertib 2 olaparib 2 camrelizumab 2 atezolizumab 2 Ipilimumab 2 Everolimus 2 trametinib 1 toripalimab 1 tilsotolimod 1 tazemetostat 1 tazarotene 1 spartalizumab 1 seviteronel 1 sargramostim 1 sacituzumab govitecan 1 rucaparib 1 roniciclib 1 romiplostim 1 pyrotinib 1 phosphorylethanolamine 1 pemigatinib 1 pembrolizumab 1 pazopanib 1 palbociclib 1 niraparib 1 magrolimab 1 lenvatinib 1 irinotecan sucrosofate 1 famitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04469530 2026-02-27

AflacST1903

Emory University

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡